METHOD FOR TREATING BRONCHIAL ASTHMA COMBINED WITH EROSIVE-ULCEROUS KLESIONS OF GASTRODUODENAL AREA

FIELD: medicine, pulmonology, gastroenterology. ^ SUBSTANCE: in 10 d after the onset of therapeutic course at applying basis therapy one should introduce antidepressant - fluvoxamine maleate for patients with observed anxious-depressive disorders at the dosage of 50 mg daily in evening period for 8...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHERNJAVSKAJA GALINA MIKHAJLOVNA, USTJUZHANINA ELENA ANATOL'EVNA, BELOBORODOVA EHL'VIRA IVANOVNA
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, pulmonology, gastroenterology. ^ SUBSTANCE: in 10 d after the onset of therapeutic course at applying basis therapy one should introduce antidepressant - fluvoxamine maleate for patients with observed anxious-depressive disorders at the dosage of 50 mg daily in evening period for 8 wk. The present innovation enables to decrease the degree of symptoms of the above-mentioned disease at the background of decreased number of relapses of bronchial asthma, in case of resistance to conventional therapy, diseases of gastroduodenal area and normalization of psychic status in patients, among them. ^ EFFECT: higher efficiency of therapy. ^ 1 ex